Rafael Holdings, Inc.
RFL- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001713863
No open-market purchases or sales by Rafael Holdings, Inc. insiders were filed in the last 90 days; 42 institutions reported holding it in 13F filings for Q2 2026, worth $12.7M in total; no superinvestor holds it.
Holders of 5% or more of RFL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Rafael Holdings, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Jonas Howard S | 13D/A | 28.40%14.7M shares | – | Jun 9, 20251 filing | Jun 9, 2025 | SEC |
| i9 PLUS, LLC | 13D/A | 7.00%3.62M shares | – | Jun 9, 20251 filing | Jun 9, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Rafael Holdings, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 9, 20255:22 PM ET | Jonas Howard S | 13D/A | 28.40%14.7M shares | – | Jun 5, 2025 | SEC |
| Jun 9, 20255:20 PM ET | i9 PLUS, LLC | 13D/A | 7.00%3.62M shares | – | Jun 5, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Rafael Holdings, Inc. shares.
No Form 144 notices for Rafael Holdings, Inc. are on file.